Mixed Lineage Leukemia 1 (MLL1) protein is a member of the SET1 (or MLL) family of histone methyltransferases. In humans, this family consists of six members: MLL1-4, SETd1A, and SETd1B (1-8). The SET1 family catalyzes methylation of histone 3 lysine 4 (H3K4), 3 an epigenetic mark that is associated with active transcription (9 -12). The human SET1 family is composed of large proteins with several well characterized functional domains involved in chromatin binding and protein-protein interactions (13, 14) (Fig. 1A). Although some of these domains differ among family members, all share a C-terminal SET (suppressor of variegation, enhancer of Zeste, trithorax) domain that confers H3K4 methyltransferase activity (15). Like many chromatin-modifying enzymes, the SET1 family works as part of multiprotein complexes that contain binding partners involved in enzymatic regulation and gene targeting. Although the majority of isolated SET1 family SET domains catalyze weak H3K4 monomethylation (H3K4me1), enhanced methylation is observed in the context of a "core complex" (16). The minimal core complex required for enhanced methylation is composed of the SET1/MLL SET domain and a subcomplex called WRAD (WD-40 repeat protein 5 (WDR5), retinoblastoma-binding protein 5 (RbBP5), absent small homeotic 2-like (ASH2L), and dumpy-30 (DPY-30)) (17)(18)(19)(20). Interestingly, SET1 family core complexes preferentially catalyze different levels of H3K4 methylation in a manner that correlates with their evolutionary lineage (16). Whereas SETd1A/B core complexes catalyze mono-, di-, and trimethylation of H3K4 (H3K4me1, H3K4me2, and H3K4me3, respectively), the MLL1 and MLL4 (also known as MLL2) core complexes predominantly catalyze mono-and dimethylation (16). In contrast, MLL2 and MLL3 core complexes catalyze predominantly H3K4 monomethylation (16). In cells, different levels of H3K4 methylation are localized to distinct genomic regions and are associated with distinct functional outcomes (21-23). Assembly of the MLL1 core complex requires a direct interaction between MLL1 and WDR5, whereby WDR5 acts to stabilize the interaction between the MLL1 SET domain and the RbBP5/ASH2L heterodimer (18,24). The MLL1-WDR5 interaction occurs via the conserved Win (WDR5 interaction) * This work was supported, in whole or in part, by the National Institutes of Health Grant R01CA140522 (to M. S. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.